Search
for

    Glossary Pyrilutamide

    topical treatment blocking androgen receptors to combat hair loss

    Pyrilutamide, also known as KX-826, is a topical non-steroidal anti-androgen being developed for the treatment of androgenetic alopecia (pattern hair loss). It works by blocking androgen receptors in hair follicles, which can help reduce hair loss and potentially promote hair regrowth.

    Learn 1 of 2

    1. Pyrilutamide Experimental topical anti-androgen, also known as KX-826
    All learn results →

    Community 10 of 393

    1. What I’ve learned From 8 Months on Pyrilutamide Reddit · 24 Sept 2026
    2. Consenus on Kx-826/pyrilutamide vs ru58841 Reddit · 7 Sept 2026
    3. Anyone having success with pyrilutamide? Reddit · 7 Aug 2026
    4. So why did the first pyrilutamide phase III fail? Reddit · 7 Aug 2026
    5. Is RU58841 safe or is pyrilutamide better option Reddit · 30 Jul 2026
    6. 2 months on topical finasteride + minoxidil + pyrilutamide Reddit · 22 Jul 2026
    7. Six month results of pyrilutamide and Alfatrodial Reddit · 20 Jul 2026
    8. My thoughts on Pyrilutamide after 6 months Reddit · 14 Jul 2026
    9. Why are there no meaningful baseline blood tests for pyrilutamide (KX-826) like there are for finasteride? Community · 6 Jul 2026
    10. Pyrilutamide and Topical Fin/Min Community · 5 Jul 2026
    All community results →

    Research 10 of 33

    1. 587 Efficacy and Safety of topical KX-826 in Male Subjects with Androgenetic Alopecia:A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study Journal of Investigative Dermatology · 2022
    2. Development and Validation of Androgen-induced Hair Loss and Anagen Induction Mouse Models for Pharmacological Evaluation of Anti-Androgenic Agents Journal of Pharmaceutical and Pharmacological Sciences · 2024 · 1 citations
    3. The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms JEADV Clinical Practice · 2022 · 1 citations
    4. Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia Figshare · 2026
    5. Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia Figshare · 2026
    6. Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia Figshare · 2026
    7. Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia Figshare · 2026
    8. Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia Figshare · 2026
    9. Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia Figshare · 2026
    10. Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia Figshare · 2026
    All research results →